ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,308Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 1107

$1.32M Total Retail Price of All Prescriptions

Rank: 44 out of 1107

660 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 660 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 660 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 17,844 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,275 717 S3 1 1
LEVOTHYROXINE SODIUM 1,133 883 2 3
SIMVASTATIN 672 515 3 5
OMEPRAZOLE 598 412 4 4
LISINOPRIL 502 380 5 2
METOPROLOL TARTRATE 495 377 6 10
ATORVASTATIN CALCIUM 484 391 7 13
AMLODIPINE BESYLATE 474 386 8 6
HYDROCHLOROTHIAZIDE 462 325 9 11
GABAPENTIN 425 259 10 9
PRAVASTATIN SODIUM 366 284 11 12
METFORMIN HCL 345 236 12 8
FUROSEMIDE 334 269 13 7
METOPROLOL SUCCINATE 307 255 14 16
ZOLPIDEM TARTRATE 296 218 15 22
ATENOLOL 272 227 16 19
DONEPEZIL HCL 258 253 17 32
POLYETHYLENE GLYCOL 3350 245 227 18 46
PANTOPRAZOLE SODIUM 243 150 19 30
CITALOPRAM HBR 241 147 20 17
POTASSIUM CHLORIDE 236 168 21 14
MELOXICAM 218 123 22 25
ISOSORBIDE MONONITRATE ER 209 190 23 34
LACTULOSE 209 205 23 89
NEXIUM 207 128 25 18
WARFARIN SODIUM 207 132 25 15
CRESTOR 201 159 27 23
SERTRALINE HCL 198 135 28 20
CARVEDILOL 196 156 29 27
CLOPIDOGREL 196 158 29 28
SYNTHROID 188 122 31 70
TRAMADOL HCL 188 87 31 26
QUINAPRIL HCL 187 168 33 145
NAMENDA 185 178 34 42
RANITIDINE HCL 171 158 35 21
SPIRONOLACTONE 164 132 36 72
ALLOPURINOL 161 112 37 36
PLAVIX 157 127 38 39
METFORMIN HCL ER 154 91 39 58
DIOVAN 152 114 40 51
MEGESTROL ACETATE 151 149 R 41 178
GLYBURIDE 148 134 R 42 68
EXELON 147 147 43 103
NOVOLOG FLEXPEN 142 113 44 230
SINGULAIR 141 128 45 65
AMITRIPTYLINE HCL 136 95 R 46 48
CYMBALTA 135 83 47 50
DIGOXIN 134 121 48 52
LEVEMIR FLEXPEN 130 99 49 213
AMLODIPINE BESYLATE-BENAZEPRIL 120 68 50 77
ALPRAZOLAM 116 74 51 87
GLIMEPIRIDE 111 84 52 43
LANSOPRAZOLE 111 77 52 102
ZETIA 110 90 54 76
LOSARTAN-HYDROCHLOROTHIAZIDE 109 96 55 66
FLUTICASONE PROPIONATE 108 75 56 38
CYCLOBENZAPRINE HCL 102 14 R 57 56
LANTUS SOLOSTAR 101 89 58 129
PROMETHAZINE HCL 101 45 R 58 44
LOSARTAN POTASSIUM 100 50 60 29
SPIRIVA 100 93 60 57
NYSTATIN 99 79 62 110
LIPITOR 99 71 62 109
LANTUS 97 75 64 49
GEMFIBROZIL 97 70 64 107
IBUPROFEN 96 32 66 63
HYDRALAZINE HCL 95 94 67 99
DILTIAZEM ER 94 67 68 139
TAMSULOSIN HCL 93 82 69 30
PROAIR HFA 93 75 69 37
CELEBREX 89 85 71 85
NITROGLYCERIN PATCH 89 88 71 184
LISINOPRIL-HYDROCHLOROTHIAZIDE 89 67 71 24
EVISTA 88 76 74 135
CLONIDINE HCL 87 72 75 53
FEXOFENADINE HCL 83 47 76 260
FENOFIBRATE 82 24 77 67
LYRICA 82 27 77 83
JANUVIA 81 73 79 60
ALENDRONATE SODIUM 79 59 80 41
TRICOR 78 53 81 95
GLYBURIDE-METFORMIN HCL 77 68 R 82 165
CILOSTAZOL 76 76 83 194
GLIPIZIDE 76 74 83 64
TEMAZEPAM 72 54 85 247
ESCITALOPRAM OXALATE 72 40 85 82
NOVOFINE AUTOCOVER 70 70 87 373
TIZANIDINE HCL 70 24 87 73
LEVETIRACETAM 69 69 89 141
FENTANYL 69 35 S2 89 105
VENLAFAXINE HCL ER 69 55 89 117
CLONAZEPAM 69 25 89 220
VENTOLIN HFA 69 32 89 97
FLUOXETINE HCL 68 30 94 47
LIDODERM 67 67 95 140
TRAZODONE HCL 66 36 96 33
VYTORIN 65 43 97 169
PREMARIN 64 19 R 98 149
LEVOFLOXACIN 64 55 98 71
MONTELUKAST SODIUM 60 47 100 118
DOXAZOSIN MESYLATE 59 45 101 92
NITROSTAT 59 32 101 188
COMBIVENT 59 36 101 112
TRIAMTERENE-HCTZ 58 58 104 62
DILTIAZEM 24HR CD 57 47 105 126
QUETIAPINE FUMARATE 57 46 105 94
MORPHINE SULFATE ER 56 0 S2 107 156
OLANZAPINE 56 0 107 176
VITAMIN D2 55 55 109 237
NAPROXEN 55 49 109 80
MECLIZINE HCL 55 53 109 114
ROPINIROLE HCL 54 38 112 69
BETAMETHASONE DIPROPIONATE 52 32 113 462
FINASTERIDE 50 50 114 130
PROPRANOLOL HCL 50 14 114 134
MIRTAZAPINE 50 34 114 61
KLOR-CON M10 50 48 114 159
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 31, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.